Oral toxicity is frequent limitation of mTOR therapy

[News]

Oral mucositis is a frequent complication in patients taking mTOR inhibitors and a major reason for dose reductions and discontinuations in clinical trials, according to a review of this class of cancer drugs.

More... (http://www.news-medical.net/news/20130204/Oral-toxicity-is-frequent-limitation-of-mTOR-therapy.aspx)